Harber Asset Management LLC Invests $5.04 Million in HCA Healthcare, Inc. $HCA

Harber Asset Management LLC bought a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 12,930 shares of the company’s stock, valued at approximately $5,041,000. HCA Healthcare makes up 3.0% of Harber Asset Management LLC’s investment portfolio, making the stock its 11th biggest holding.

Other large investors also recently made changes to their positions in the company. Nomura Asset Management Co. Ltd. lifted its stake in HCA Healthcare by 6.2% in the 4th quarter. Nomura Asset Management Co. Ltd. now owns 64,237 shares of the company’s stock valued at $29,990,000 after acquiring an additional 3,724 shares in the last quarter. Advisors Capital Management LLC raised its holdings in shares of HCA Healthcare by 61.5% in the fourth quarter. Advisors Capital Management LLC now owns 6,836 shares of the company’s stock valued at $3,192,000 after purchasing an additional 2,604 shares during the last quarter. Arrowstreet Capital Limited Partnership boosted its holdings in HCA Healthcare by 11.9% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 2,311,112 shares of the company’s stock worth $1,078,966,000 after purchasing an additional 245,887 shares during the last quarter. Liberty Wealth Management LLC acquired a new stake in HCA Healthcare in the 4th quarter valued at $1,905,000. Finally, Sunbelt Securities Inc. boosted its stake in shares of HCA Healthcare by 171.7% during the 1st quarter. Sunbelt Securities Inc. now owns 6,242 shares of the company’s stock worth $2,954,000 after buying an additional 3,945 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

Shares of HCA Healthcare stock opened at $429.08 on Friday. HCA Healthcare, Inc. has a 52-week low of $353.99 and a 52-week high of $556.52. The stock has a market cap of $92.90 billion, a PE ratio of 14.36, a PEG ratio of 1.41 and a beta of 1.10. The firm has a 50-day moving average of $397.16 and a 200-day moving average of $444.14.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.56 by $0.03. The business had revenue of $20.23 billion for the quarter, compared to the consensus estimate of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The firm’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same quarter in the prior year, the business posted $6.84 earnings per share. Equities research analysts predict that HCA Healthcare, Inc. will post 29.47 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be given a $0.78 dividend. The ex-dividend date is Wednesday, September 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.7%. HCA Healthcare’s payout ratio is presently 10.45%.

Analysts Set New Price Targets

HCA has been the topic of a number of analyst reports. Jefferies Financial Group set a $450.00 price objective on HCA Healthcare in a research note on Tuesday, July 14th. Morgan Stanley decreased their price objective on shares of HCA Healthcare from $425.00 to $380.00 and set an “underweight” rating for the company in a research report on Monday, July 27th. Wells Fargo & Company raised their target price on shares of HCA Healthcare from $369.00 to $381.00 and gave the company an “equal weight” rating in a research note on Monday, August 3rd. Robert W. Baird lowered their price target on HCA Healthcare from $396.00 to $393.00 and set a “neutral” rating on the stock in a research report on Monday, July 27th. Finally, Argus reduced their target price on HCA Healthcare from $560.00 to $500.00 and set a “buy” rating for the company in a research note on Monday, May 4th. Fourteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $462.64.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.